Peripheral blood CD34 donor chimerism and flow cytometry for measurable residual disease are complementary assays for predicting relapse of AML after allogeneic transplantation in AML
Year: 2025
Type: conference-abstract
Source: Blood
Institutions: The Alfred Hospital, Alfred Health, Monash University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417020673
Cites:
Cited by:
Related to:
